Surgical microscopy system and method for performing eye surgery
    1.
    发明授权
    Surgical microscopy system and method for performing eye surgery 有权
    手术显微镜系统和执行眼部手术的方法

    公开(公告)号:US08486085B2

    公开(公告)日:2013-07-16

    申请号:US13040727

    申请日:2011-03-04

    IPC分类号: A61F9/00

    CPC分类号: A61B3/107 A61B3/113 A61B3/13

    摘要: A surgical microscopy system comprises microscopy optics for generating an image of an eye under surgery. A pattern generator generates a pattern to be superimposed with the image. An eye-tracker is provided for tracking a position of the superimposed pattern with respect to the image in case of a movement of the eye. The superimposed pattern comprises pattern elements that are equally distributed on first and second circles of different sizes, in order to give assistance when placing a suture during a corneal transplant. The superimposed pattern may also provide an assistance for orientating a toric intra-ocular lens.

    摘要翻译: 手术显微镜系统包括用于在手术下产生眼睛图像的显微镜光学器件。 图案生成器生成与图像叠加的图案。 提供了一种眼睛跟踪器,用于在眼睛移动的情况下跟踪相对于图像的叠加图案的位置。 叠加图案包括均匀分布在不同大小的第一和第二圆上的图案元件,以便在角膜移植期间放置缝合线时给予帮助。 叠加图案还可以提供用于定向复曲面眼内透镜的辅助。

    CINNAMOYL-PIPERAZINE DERIVATIVES AND THEIR USE AS PAR-1 ANTAGONISTS
    3.
    发明申请
    CINNAMOYL-PIPERAZINE DERIVATIVES AND THEIR USE AS PAR-1 ANTAGONISTS 有权
    CINNAMOYL-PIPERAZINE衍生物及其作为PAR-1拮抗剂的用途

    公开(公告)号:US20090176803A1

    公开(公告)日:2009-07-09

    申请号:US12305584

    申请日:2007-06-19

    CPC分类号: C07D295/185

    摘要: The present invention relates to compounds of general formula (I): wherein: R1 represents: halogen, CN or NO2; R2 represents: hydrogen or halogen; n represents: 1 or 2; R3 represents: phenyl substituted by one or more halogens or C1-C6 alkyls; or a cyclohexyl; as well as the therapeutically-acceptable salts or solvates thereof. These compounds are useful as protease-activated receptor-1 (PAR-1) antagonists, particularly in the treatment of thrombosis.

    摘要翻译: 本发明涉及通式(I)的化合物:其中:R1表示:卤素,CN或NO2; R2表示:氢或卤素; n表示1或2; R3表示:被一个或多个卤素或C 1 -C 6烷基取代的苯基; 或环己基; 以及其治疗上可接受的盐或溶剂合物。 这些化合物可用作蛋白酶激活受体-1(PAR-1)拮抗剂,特别是治疗血栓形成。

    Methanesulphonate salt of an arylpiperazine derived from tryptamine and
its solvates for pharmaceutical use
    5.
    发明授权
    Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use 失效
    衍生自色胺的芳基哌嗪的甲磺酸盐及其药物用溶剂化物

    公开(公告)号:US6110917A

    公开(公告)日:2000-08-29

    申请号:US202539

    申请日:1998-12-16

    CPC分类号: C07D209/16

    摘要: The invention discloses the methanesulphonate salt of 4-(4-{2-[3-(2-amino-ethyl)-1H-indol-5-yloxy]-acetyl}-piperazin-1-yl)-benzonitrile, its solvates or hydrates as well as the preparation of the said salt. The invention also discloses the pharmaceutical compositions containing the said salt, useful in the preparation of medicines for treating vasospastic disorders.

    摘要翻译: PCT No.PCT / FR97 / 01053 Sec。 371日期1998年12月16日第 102(e)日期1998年12月16日PCT提交1997年6月12日PCT公布。 公开号WO97 / 48680 PCT 日期1997年12月24日本发明公开了4-(4- {2- [3-(2-氨基 - 乙基)-1H-吲哚-5-基氧基] - 乙酰基} - 哌嗪-1-基) - 苄腈,其溶剂合物或水合物以及所述盐的制备。 本发明还公开了含有所述盐的药物组合物,其可用于制备治疗血管痉挛性疾病的药物。

    Phenylpentadienoyl derivatives and their use as PAR 1 antagonists
    6.
    发明授权
    Phenylpentadienoyl derivatives and their use as PAR 1 antagonists 有权
    苯戊二烯酰基衍生物及其作为PAR 1拮抗剂的用途

    公开(公告)号:US08022064B2

    公开(公告)日:2011-09-20

    申请号:US12305447

    申请日:2007-06-19

    摘要: The present invention relates to compounds of general formula (I): wherein: R1 and R2, identical or different, represent: an atom of hydrogen or halogen, CN or NO2, with R1 and R2 not representing hydrogen simultaneously, m represents: 1 or 2 n represents: 0, 1 or 2 R3 represents: phenyl substituted or not by one or more residues chosen among halogen, hydroxyl or C1-C6 alkyl; C2-C6 alkyl substituted or not by one or more residues chosen among halogen or hydroxyl; cycloalkyl; pyridine; thiophene; pyrrole substituted or not by C1-C6 alkyl; thiazole or furan; or the therapeutically-acceptable salts or solvates thereof.

    摘要翻译: 本发明涉及通式(I)的化合物:其中:R1和R2相同或不同,代表氢原子或卤素,CN或NO2,其中R1和R2不同时代表氢,m表示:1或 2 n表示:0,1或2 R 3表示:被一个或多个选自卤素,羟基或C 1 -C 6烷基的残基取代或不被取代的苯基; 被一个或多个选自卤素或羟基的残基取代或不被其取代的C 2 -C 6烷基; 环烷基 吡啶; 噻吩 被C1-C6烷基取代或未取代的吡咯; 噻唑或呋喃; 或其治疗上可接受的盐或溶剂化物。

    Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
    10.
    发明授权
    Cinnamoyl-piperazine derivatives and their use as par-1 antagonists 有权
    肉桂酰哌嗪衍生物及其作为par-1拮抗剂的用途

    公开(公告)号:US08513258B2

    公开(公告)日:2013-08-20

    申请号:US13476487

    申请日:2012-05-21

    IPC分类号: A61K31/495 C07D295/185

    CPC分类号: C07D295/185

    摘要: The present invention relates to compounds of general formula (I): wherein: R1 represents: halogen, CN or NO2; R2 represents: hydrogen or halogen; n represents: 1 or 2; R3 represents: phenyl substituted by one or more halogens or C1-C6 alkyls; or a cyclohexyl; as well as the therapeutically-acceptable salts or solvates thereof. These compounds are useful as protease-activated receptor-1 (PAR-1) antagonists, particularly in the treatment of thrombosis.

    摘要翻译: 本发明涉及通式(I)的化合物:其中:R1表示:卤素,CN或NO2; R2表示:氢或卤素; n表示1或2; R3表示:被一个或多个卤素或C 1 -C 6烷基取代的苯基; 或环己基; 以及其治疗上可接受的盐或溶剂合物。 这些化合物可用作蛋白酶激活受体-1(PAR-1)拮抗剂,特别是治疗血栓形成。